Our recent findings suggest that β-actin acts as a tumor suppressor, inducing epithelial differentiation, inhibiting cell growth, and curbing invasion in lung and colon carcinoma cell cultures, as well as inhibiting tumor growth in vivo. Here, ACTB is linked to neoplasm.